Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study.
J Thorac Oncol
; 15(3): 392-403, 2020 03.
Article
in En
| MEDLINE
| ID: mdl-31634667
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Thorac Oncol
Year:
2020
Document type:
Article
Country of publication: